Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GreenGene F in Hemophilia A (Phase III, China)
CTR20170235Phase 3Active
- Sponsor
- GC Biopharma
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of GreenGene F in hemophilia A, sponsored by GC Biopharma. Started May 2017; status: active.
02
Drugs
GreenGene F
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20170235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170235.